Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GeoVax Labs, Inc. - Common Stock (NQ: GOVX )

1.540 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 556,296
Open 1.540
Bid (Size) 1.520 (10)
Ask (Size) 1.600 (20)
Prev. Close 1.540
Today's Range 1.500 - 1.620
52wk Range 1.090 - 11.18
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeoVax Labs Inc. (NASDAQ: GOVX) Featured in Coverage of the 37th Annual ROTH Conference
Via Investor Brand Network
Exposures COVID-19
GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
-37.90%
-37.90%
1 Month
-1.91%
-1.91%
3 Month
-35.83%
-35.83%
6 Month
-50.80%
-50.80%
1 Year
-27.01%
-27.01%

More News

Read More
GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK
Via TheNewswire.com
GeoVax to Present at the 37th Annual Roth Conference
Via NewMediaWire
Exposures COVID-19
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health
Via TheNewswire.com
GeoVax to Present at the 37th Annual Roth Conference
Via TheNewswire.com
Exposures COVID-19
Registration is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025
Via TheNewswire.com
Exposures COVID-19
Registration is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025
Via NewMediaWire
Exposures COVID-19
GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy
Via NewMediaWire
Topics Economy
Exposures Supply Chain
GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy
Via TheNewswire.com
Topics Economy
Exposures Supply Chain
GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern
Via NewMediaWire
Topics Death
Exposures Death
GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern
Via TheNewswire.com
Topics Death
Exposures Death
GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness
Via NewMediaWire
Exposures COVID-19
GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness
Via TheNewswire.com
Exposures COVID-19
Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification
Via NewMediaWire
Topics Economy Supply Chain
Exposures Supply Chain
Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification
Via TheNewswire.com
Topics Economy Supply Chain
Exposures Supply Chain
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health
Via NewMediaWire
GeoVax to Present at the Emerging Growth Conference on February 19, 2025
Via NewMediaWire
GeoVax to Present at the Emerging Growth Conference on February 19, 2025
Via TheNewswire.com
GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement Award
Via NewMediaWire
GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement Award
Via TheNewswire.com
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor Conference
Via NewMediaWire
Exposures COVID-19
GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor Conference
Via TheNewswire.com
Exposures COVID-19
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.